Last reviewed · How we verify
NCT06309641
Methemoglobinemia Following Intravenous Iron Treatment
trial testing Blood sample after treatment in Methemoglobinemia in 50 participants. Completed in 13 October 2025.
13 October 2025
Quick facts
| Lead sponsor | Claudia Seiler |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 2 September 2024 |
| Primary completion | 13 October 2025 |
| Estimated completion | 13 October 2025 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Blood sample after treatment
- Case reports
Conditions studied
- Methemoglobinemia — all drugs for Methemoglobinemia →
- Anemia — all drugs for Anemia →
- Iron Deficiencies — all drugs for Iron Deficiencies →
- Side Effect — all drugs for Side Effect →
Sponsor
Claudia Seiler
Who can join
18 and older, any sex, with Methemoglobinemia or Anemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Methemoglobinemia as a side effect of treatment with intravenous iron has not previously been described. This study aims to assess methemoglobin levels in patients with anemia following treatment with intravenous iron, administered as ferric carboxymaltose or ferric derisomaltose.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06309641
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06309641 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Claudia Seiler
- Last refreshed: 9 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06309641.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing